13.10.2023 - Procedure started

EMA’s human medicines committee (CHMP) has started a review of the medicine Ocaliva (obeticholic acid), used to treat adults with primary biliary cholangitis (PBC).

Further information

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

Ocaliva